New York A 1707: Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Status: SIGNED CHAP.738 (as of 2023-12-22)

State: New York · Session: 2023-2024 · Bill: A 1707

Sponsors: Daniel Rosenthal, Albert A. Stirpe, Alex Bores, Dana Levenberg, David Weprin, Demond Meeks, Donna Lupardo, Gina Sillitti, Grace Lee, Inez E. Dickens, Jaime R. Williams, Jeffrey Dinowitz, Jessica Gonzalez-Rojas, Jo Anne Simon, John T. McDonald III, John Zaccaro Jr., Jonathan Jacobson, Karines Reyes, Kimberly Jean-Pierre, Linda Rosenthal, Marianne Buttenschon, MaryJane Shimsky, Pamela J. Hunter, Philip Ramos, Rebecca Seawright

View New York A 1707 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.